73% of Series B and later rounds in 2026 close at flat or down valuations. Investors reprice your equity. They do not reprice your patents. That gap between share price and IP value is the single biggest lever founders ignore during a down round, and it costs them millions in dilution they did not need to take.
Hayat Amin argues that a down round IP strategy is not a defensive move. It is the most aggressive capital play a founder can make when the market turns against them. The founders who run this playbook walk into their down round with leverage. The ones who do not hand it to their investors.
What Happens to Your IP in a Down Round?
Your IP retains its appraised value even when your cap table gets repriced. Patents, trade secrets, proprietary data sets, and trademarks are independently appraised assets with market values derived from licensing revenue potential, claim breadth, and competitive coverage, not from your last preferred share price. A company trading down from a $50M post-money to a $25M post-money still owns the same patent portfolio, the same proprietary data, and the same trade secrets it held before the round.
This matters because investors in a down round use one number: the new share price. That number does not account for the $8M, $12M, or $20M in appraised IP sitting on the balance sheet. Hayat Amin calls this the "valuation floor problem": the floor of your company's worth is the replacement cost of your IP, and most term sheets in a down round price the company below that floor.
The result is structural. Founders who accept a down round without an independent IP appraisal are giving away equity at a price that does not reflect the assets behind it. A 2026 EisnerAmper study found that companies with independently appraised IP portfolios negotiated 22% less dilution in down rounds than those without.
Why Do Investors Reprice Equity but Not IP in a Down Round?
Investors reprice equity because equity tracks revenue trajectory, not asset value. A down round is a statement about future cash flows, not about the underlying technology. Your IP, by contrast, retains value because patents have a fixed 20-year economic life, trade secrets do not expire at all, and proprietary data assets appreciate as they grow. These assets are valued by the income they can generate through licensing, not by the current ARR of the operating company.
This is why IP-backed lenders underwrite the patent schedule, not the P&L. Venture debt providers like Western Technology Investment and Horizon assign LTV ratios of 20% to 40% against appraised IP value. If a lender will lend $4M against your patents at a $10M appraisal, your investor has no justification pricing the entire company at $8M.
The math is simple. The down-round share price says your company is worth $25M. Your IP appraisal says the patents alone are worth $14M. That means the investor is paying $11M for the revenue, team, market position, and everything else. When you put that number in front of a lead investor, the negotiation shifts.
What Is Hayat Amin's Down-Round IP Shield Framework?
Hayat Amin's Down-Round IP Shield Framework is a five-step process that uses independent IP valuation to set a negotiation floor before the term sheet is signed. Beyond Elevation deploys this framework for founders facing valuation compression, and the median outcome is 18% to 25% less dilution than the initial term sheet proposed.
Step 1: Commission an independent IP appraisal before the round opens. Use the income approach, not the cost approach. The income approach values patents by the licensing revenue they could generate over their remaining life. The cost approach values them at replacement cost, which is always lower. Get this done 60 to 90 days before you expect to close. A credentialed appraisal (ASA or AICPA standard) carries weight that an internal estimate does not.
Step 2: Separate the IP narrative from the equity narrative. In your investor materials, present the IP portfolio as a distinct asset class with its own valuation. Show the claim coverage map, the licensing revenue potential, and the competitive moat score. This forces investors to price two things: the operating business and the IP. Most term sheets collapse them into one number. Do not let that happen.
Step 3: Model the IP-backed alternative. Before accepting dilutive terms, model what an IP-backed loan would cost versus the equity dilution. A $3M IP-backed loan at 12% over three years costs $1.08M in interest. The same $3M as equity in a down round at a $15M pre-money costs 20% of the company. At a $50M exit, that 20% is $10M. The debt costs $1.08M. Show this math to your board.
Step 4: Use IP collateral to bridge to better terms. If the down-round terms are unacceptable, use the IP appraisal to secure bridge financing from an IP-backed lender. This buys 6 to 12 months of runway without the dilution. Founders who bridge on IP collateral often raise the next round at a flat or up valuation because the additional runway lets them hit the milestones investors wanted to see.
Step 5: Negotiate anti-dilution carve-outs for IP value. In the term sheet negotiation, argue that the anti-dilution ratchet should account for appraised IP value. If the company's floor value, as established by the independent appraisal, is $14M, then the ratchet should not drive the effective share price below the per-share equivalent of that floor. This is uncommon but defensible, and Hayat Amin says the founders who ask for it get a modified version 40% of the time.
How Does a Down Round IP Strategy Change the Term Sheet?
A down round IP strategy shifts the negotiation from "how much dilution will you accept" to "how much of this company's value is locked in assets you cannot reprice." The term sheet changes in three measurable ways. First, the pre-money valuation rises because the IP appraisal establishes a credible floor. Second, the liquidation preference multiple drops because the investor's downside is backstopped by the IP collateral. Third, the participating preferred structure weakens because the founder can credibly threaten to bridge on IP debt instead of accepting punitive equity terms.
Beyond Elevation has seen these dynamics play out across multiple engagements. In one 2025 restructuring, a SaaS company facing a 55% down round used an independent patent appraisal to reduce the round discount to 31%. The patent portfolio, covering seven granted claims on proprietary data pipeline architecture, appraised at $9.2M against a proposed $16M post-money. The lead investor revised upward to $22M post-money after reviewing the appraisal and the licensing revenue model behind it.
The 10.2x stat reinforces this: companies with patents are 10.2x more likely to secure early-stage funding. In a down round, that same signal works in reverse. Investors do not want to walk away from a deal where the IP alone justifies a meaningful portion of the valuation. Walking away means the next investor gets the IP at the discount you created.
When Should You Start Your Down Round IP Strategy?
Start the moment your runway drops below 12 months and your growth metrics are below the threshold your existing investors set for the next round. Do not wait until the term sheet arrives. An IP appraisal takes 45 to 90 days for a thorough income-approach analysis. If you start the appraisal when the term sheet lands, you have already lost the negotiation window.
Hayat Amin reminds founders that the worst time to discover the value of your IP is during a down round. The best time is 18 months before you need it. The second-best time is right now. Beyond Elevation's IP valuation advisory runs the appraisal, builds the licensing revenue model, and prepares the investor-facing IP deck in a single engagement. The output is a credentialed asset valuation that shifts the negotiation before it begins.
FAQ
Does an IP appraisal actually change a down-round valuation?
Yes. An independent, credentialed IP appraisal (ASA or AICPA standard) establishes an asset floor that investors must account for. Founders with appraised IP portfolios negotiate 18% to 25% less dilution on average because the appraisal forces the pre-money conversation above the replacement cost of the underlying assets.
Can I use patents as collateral instead of raising a down round?
Yes. IP-backed lenders like Western Technology Investment and Horizon underwrite patent portfolios at 20% to 40% LTV. A $10M appraised portfolio supports $2M to $4M in debt financing at 8% to 15% interest, which is dramatically cheaper than the equity dilution in a down round. Read the full IP-backed lending playbook here.
What types of IP hold value in a down round?
Granted patents with broad claims and multi-jurisdiction coverage hold the most value. Trade secrets, particularly AI model weights, training data, and proprietary algorithms, retain value because they do not expire. Proprietary data assets hold value proportional to their uniqueness, size, and licensing potential. Trademarks and copyrights hold value but are rarely significant enough to shift a term sheet negotiation.
How long does an IP appraisal take?
A thorough income-approach IP appraisal takes 45 to 90 days. The timeline depends on portfolio size, claim complexity, and the number of licensing comparables available. Founders should start the process at least 60 days before they expect to negotiate term sheet terms.
What if my patents are still pending, not granted?
Pending patents carry less weight than granted patents in a down-round negotiation. However, a well-structured provisional filing with broad claims still signals defensibility. Lenders typically discount pending patents by 40% to 60% relative to granted claims, but they do not ignore them entirely. The key is prosecution history: patents that have survived office actions and are close to grant carry significantly more credibility than freshly filed provisionals.